Aflatoxin Residues in Milk of Dairy Cows after Ingestion of Naturally Contaminated Grain

1986 ◽  
Vol 49 (10) ◽  
pp. 781-785 ◽  
Author(s):  
R. A. FROBISH ◽  
B. D. BRADLEY ◽  
D. D. WAGNER ◽  
P. E. LONG-BRADLEY ◽  
H. HAIRSTON

Thirty-two lactating Holstein cows, blocked according to level of milk production, were fed cottonseed meal contaminated with aflatoxin B1, (AFB1) (0, 94, 241 and 500 μg/kg) as 20% of their ration (equivalent to 0, 20, 48 and 104 μg/kg in complete feed). Within 12 h, aflatoxin M1 (AFM1) appeared in the milk of all cows receiving contaminated feed. The mean AFM1 concentrations in the milk approached steady-state conditions (0.35, 0.63 and 1.61 μg/L for treatments of 20, 48 and 104 μg AFB1/kg, respectively) at 24 h and returned to the Food and Drug Administration action level of 0.5 μg/L or lower within 24 h after removal of the contaminated feed. The ratio of AFB1 in the feed to AFM1 in the milk averaged 66:1. The mean percent of daily AFB1 intake that was transferred to AFM1 was 1.74. This value was unaffected by the concentration of AFB1 in the feed (1.89, 1.55 and 1.81% transferred for treatments of 20, 48 and 104 μg AFB1/kg, respectively). Although increased milk production had no effect on the concentration of AFM1 in the milk, it had a positive effect (P ≤ 0.01) on the percent of AFB1 intake transferred to AFM1 (2.14 vs 1.35%). In a second trial, 16 additional cows were fed either naturally contaminated cottonseed meal or corn (44 and 49 μg/kg, respectively, on a complete feed basis). The percent of AFB1 intake secreted as AFM1 was affected (P ≤ 0.02) by the source of contamination (1.73 vs. 1.32% for the cottonseed meal and corn treatments, respectively). The AFM1 concentrations in the milk were not significantly different (P>0.05).

Toxins ◽  
2019 ◽  
Vol 11 (3) ◽  
pp. 161 ◽  
Author(s):  
Yongpeng Guo ◽  
Yong Zhang ◽  
Chen Wei ◽  
Qiugang Ma ◽  
Cheng Ji ◽  
...  

This study was conducted to determine the effect of Bacillus subtilis ANSB060 biodegradation product (BDP) in reducing the milk aflatoxin M1 (AFM1) content of dairy cows fed a diet contaminated with aflatoxin B1 (AFB1). Twenty-four Chinese Holstein cows (254 ± 19 d in milk; milk production 19.0 ± 1.2 kg d−1) were assigned to three dietary treatments, as follows: (1) control diet (CON), consisting of a basal total mixed ration (TMR); (2) aflatoxin diet (AF), containing CON plus 63 μg of AFB1 kg−1 of diet dry matter; and (3) aflatoxin diet plus BDP (AF + BDP), containing AF plus BDP at 0.2% of diet dry matter. The experiment lasted 12 days, including an AFB1-dosing period from days one to eight, followed by a clearance period from days nine to twelve. Milk samples were collected on days 2, 4, 6, and 8–12, and the plasma was sampled on day 9, before morning feeding. Short-term AFB1 exposure did not affect the milk production and composition. The plasma biochemical indices, except for lactic dehydrogenase (LDH), were also not changed by the AFB1 intake. The plasma LDH level was significantly elevated (p < 0.05) following dietary treatment with AFB1, while no significant difference was observed between the AF + BDP and CON treatments. Adding BDP to the AFB1-contaminaed diet resulted in a significant reduction in AFM1 concentration (483 vs. 665 ng L−1) in the milk, AFM1 excretion (9.14 vs. 12.71 μg d−1), and transfer rate of dietary AFB1 to milk AFM1 (0.76 vs. 1.06%). In conclusion, the addition of BDP could be an alternative method for reducing the dietary AFB1 bioavailability in dairy cows.


2018 ◽  
Vol 36 (4) ◽  
pp. 319-325 ◽  
Author(s):  
Noa Gordon ◽  
Salomon M. Stemmer ◽  
Dan Greenberg ◽  
Daniel A. Goldstein

Purpose Cancer drug prices at launch have increased in recent years. It is unclear how individual drug prices change over time after launch and what market determinants influence these changes. We measured the price trajectories of a cohort of cancer drugs after their launch into the US market and assessed the influence of market structure on price changes. Methods We studied the changes in mean monthly costs for a cohort of 24 patented, injectable anticancer drugs that were approved by the US Food and Drug Administration between 1996 and 2012. To account for discounts and rebates, we used the average sales prices published by the Centers for Medicare and Medicaid Services. Costs were adjusted to US general and health-related inflation rates. For each drug, we calculated the cumulative and annual drug cost changes. We then used a multivariable regression model to evaluate the association between market and cost changes over time. Results With a mean follow-up period of 8 years, the mean percent change in cost for all drugs was +25% (range, −14% to +96%). After adjusting for inflation, the mean cost change was +18% (range, −16% to +59%). Rituximab and trastuzumab followed a similar pattern in cost increases over time, and the inflation-adjusted monthly costs rose since approval by 49% and 44%, respectively. New supplemental US Food and Drug Administration approvals, new off-label indications, and new competitors did not influence the annual cost change rates. Conclusion Anticancer drug costs may change substantially after launch. Regardless of competition or supplemental indications, there is a steady increase in costs of patented anticancer agents over time. New regulations may be needed to prevent additional increases in drug costs after launch.


1985 ◽  
Vol 48 (1) ◽  
pp. 11-15 ◽  
Author(s):  
RALPH L. PRICE ◽  
J. H. PAULSON ◽  
OTIS G. LOUGH ◽  
CONRAD GINGG ◽  
ANDY G. KURTZ

Whole cottonseed determined to have aflatoxin B1 (AFB1) levels of 5, 31, 104, 280, and 560 μg/kg was fed as 15% of the total dairy ration to a commercial herd of 90 grade Holstein dairy cattle for 70 d. Milk from the bulk tank was sampled either daily or after each milking and analyzed for aflatoxin M1 (AFM1). The ratio for AFB1 in the dairy ration to AFM1 in the milk averaged 75 to 1 under conditions and at levels tested with no consistent relation to the level of AFB1 in the feed. Approximately 1.6% conversion occurred during the steady state of consumption and secretion. The federal action level of 0.5 μg AFM1/L of milk would be produced by cows consuming a ration containing 15% whole cottonseed contaminated with approximately 250 μg AFB1/kg.


2016 ◽  
Vol 99 (8) ◽  
pp. 6263-6273 ◽  
Author(s):  
I.M. Ogunade ◽  
K.G. Arriola ◽  
Y. Jiang ◽  
J.P. Driver ◽  
C.R. Staples ◽  
...  

1987 ◽  
Vol 8 (4) ◽  
pp. 163-167 ◽  
Author(s):  
C.A. Bartzokas ◽  
J.E. Corkill ◽  
T. Makin

AbstractThe initial and cumulative efficacy of two antiseptic handwash preparations in eliminating Serratia marcescens from hands was evaluated on volunteers. Two antiseptics with persistent skin antibacterial activity, 4% chlorhexidine gluconate in detergent and 1.5% triclosan in natural soap, were studied in a new protocol designed according to Food and Drug Administration guidelines. After a single handwash, both preparations exhibited a degerming action statistically superior to the mechanical elimination of the marker organism that was achieved by the nonmedicated controls. Following a further nine hand recontamination sequence with 109 colony-forming units (cfu)/mL S marcescens (mean pre-disinfection baseline, log10 6.6), the efficacy of chlorhexidine and triclosan was significantly augmented: the mean log10 reduction factors were 4.15 and 3.78, respectively. In the absence of internationally accepted testing standards for antiseptic handwash products, the significance of protocol variables is discussed. The advantages to preventative microbiology of antiseptics with persistent skin antibacterial activity are highlighted.


2015 ◽  
Vol 69 (6) ◽  
pp. 651-656 ◽  
Author(s):  
Danka Spiric ◽  
Jasna Djinovic ◽  
Vesna Jankovic ◽  
Branko Velebit ◽  
Tatjana Radicevic ◽  
...  

Atypical weather and climate conditions during the spring and summer 2012th were assumed to be the main reason for the aflatoxins contamination of corn crops in Serbia. High humidity in spring, and summer temperatures above the average contributed to the increased possibility of mycotoxins occurance in cereals in the fields. As a consequence, at the begining of 2013th contaminated corn used for dairy cows diet had negative impact on the safety of cow milk. The routine laboratory control data revealed an increased content of aflatoxin M1 in milk samples. Large number of raw milk and various feedstuff samples were collected from February to April 2013th and were analysed for the presence of aflatoxin M1 (AFM1) and aflatoxin B1 respectively. The collected samples were a part of enhanced self-control plans of the large dairy farms. Quantitative competitive and sandwich types of ELISA tests were used for the screening analysis of the feed and milk samples. Confirmation of the positive results obtained by ELISA tests was performed by UPLC-MS/MS method. Out of 281 samples of complete mixtures for dairy cows, 67 samples (24%) contained aflatoxin B1 quantities higher than the MRL of 0,005 mg/kg [4]. Corn samples were also tested for the presence of aflatoxin B1 revealing contamination of 22% above the MRL (0.03mg/kg). Aflatoxin M1 content in the 934 positive milk samples ranged from 0,005- 1,25 ?g/kg. The corresponding feed samples of sunflower meal, hay silage, corn silage and sugar beet pulp were screening negative, with the content of aflatoxin B1 less than 2 ?g/kg. The main source of aflatoxins were corn samples, wholemeal and feed mixtures derived from contaminated corn. The contamination peak was during March 2013, when 65% of milk samples contained amounts of aflatoxin M1 higher than 0,05 ?g/kg, and 13% of milk samples contained amounts higher than 0,5 ?g/kg.


2016 ◽  
Vol 94 (suppl_5) ◽  
pp. 649-649
Author(s):  
M. Aronovich ◽  
C. Perali ◽  
C. A. D. R. Rosa ◽  
A. A. Castagna ◽  
E. Rodrigues

Sign in / Sign up

Export Citation Format

Share Document